Click here for the latest information on Motif IPOs
I created this page to archive the history of frequent updates on the main Motif IPOs page which was getting too long.
Update 05/14/2018: Up to date as of noon.
Update 04/17/2018: Mereo Pharmaceuticals IPO now available on Motif. Underwriting by Cowen.
Update 04/13/2018: GrafTech International IPO now available on Motif.
Update 03/22/2018: The Royalty Flow IPO is now available on Motif. Read more about the Royalty IPO from this previously published article on Access IPOs.
Update 03/20/2018: Three deals went live today, all spot secondaries. Xencor, Proteostasis, Arena Pharmaceuticals.
No signs of Dropbox IPO yet. Not holding my breath. Only saw it offered to TD Ameritrade customers. Motif and even Fidelity may get shut out.
Update 03/15/2018: Added La Jolla Pharmaceuticals and PolyPid
Update 02/24/2018: Doing some work on the Dropbox IPO today for a future piece. Underwriting is by Goldman Sachs and J.P. Morgan. Both have underwritten IPOs on the Motif Platform in the past. So we’ll be keeping an eye on this one, especially when we get within 10 days of the closing.
Update 02/22/2018: a few updates in the table below for Aimmune and 1347 Property Insurance.
Aspen REIT was withdrawn for what is likely a lack of interest in single property REITs.
Update 02/21/2018: Aspen REIT Reg A+ IPO was pulled. Here’s the statement:
“Interest in our single-asset real estate offering was strong among international and high-net-worth investors. However, we decided to pull the deal in order to re-tool our crowd funding distribution channel in order to create a seamless conversion of the robust traffic to our site,” said Stephane De Baets, Chief Executive Officer, President and Chairman of Aspen REIT. “We continue to believe the St. Regis Aspen Resort is an extremely attractive trophy asset and there is a future for publicly traded single-asset REITs.”
Update 02/02/2018: Interesting new Reg A+ opportunity on Motif announced today. The Aspen REIT IPO is looking to raise $33 million to buy a single property in Aspen. Here are the specifics according to the Motif website:
Aspen REIT, Inc. is a Maryland corporation that has been formed to own the St. Regis Aspen Resort in Aspen, Colorado. We are a single-asset REIT and currently intend to own only the St. Regis Aspen Resort. Therefore, an investment in our common stock is an investment in the St. Regis Aspen Resort.
These single property REITs come with more risk. This is a rare opportunity, however, to invest in a very expensive real estate market that also should earn a profit from hotel operations. Read the offering circular here.
Update 02/01/2018: Victory Capital IPO now available on Motif. Underwriting by J.P. Morgan. Scheduled to IPO on 02/08/2018. This is a $200+ million IPO.
Update 01/31/2018: Added Evolus IPO to the upcoming Motif IPO list.
Update 01/30/2018: Amarin Corporation spot secondary priced at $3.65. Allocations came in at 46%.
Update 01/29/2018: Amarin Corporation announced a spot secondary offering after the close today. $70 million offering should price tomorrow morning. Orders accepted through Motif until 7 am EST tomorrow. Underwriting by Cantor Fitzgerald.
Update 01/25/2018: EyeNovia IPO priced at the bottom of the range, $10. Investors reporting 100% allocation from Motif. Hoping that’s not a bad sign.
Update 01/24/2018: Looks like Motif was shut out by Goldman Sachs on the PagSeguro Digital IPO deal. Too bad, shares jumped 36%.
Hard to keep up with all these deals!
Rocket Pharmaceuticals spot secondary email sent after the close yesterday. Priced at $13.25 this morning, representing a 12.8% discount to prior close. Allocations came in at 25% of requested.
Announced this morning, Blink Charging Co. secondary offering. Small deal led by Joseph Gunnar. No pricing set yet.
Update 01/23/2018: One Stop Systems IPO added to the table below. Estimated at $20 million. Underwriting by Roth Capital Partners.
Update 01/22/2018: Added two IPOs to the list today. PagSeguro Digital IPO is a Goldman Sachs-led deal. I missed this Friday because the alert email from Motif went to my spam. Check you spam/junk folders for Motif emails! This is a large deal estimated at $1.75 billion. The company is a payments solutions provider in Brazil.
Also added the small Genprex IPO led by newcomer underwriter, Network 1 Financial.
Updates 01/19/2018: Thanks to a reader suggestion, I’ve added an Allocation % column to the table below. The web page is too narrow to fit it all in one view, so you need to used the scrollbar at the bottom to see it.
This is the percent of allocation that was granted by Motif compared to what was requested. So if you requested $5,000 and received only $2,500 worth of stock, the allocation was 50%.
I was able to source some data from the archives of this page. But I need your help to fill in the blanks. If you have any records of the allocations you received vs. requested, please send me an email. Use this contact form.
Update 01/19/2018: Received some allocations from a reader. Here they are:
- Nine Energy Service – 40.46% of requested amount
- ADT – 44.42% of requested amount
Update 01/17/2018: A company called Genocea Biosciences is offered a spot secondary today for warrants on the Motif platform underwritten by Cantor Fitzgerald.
Another IPO, EyeNovia is also available today. Underwriting by Ladenburg Thalmann.
Update 01/15/2018: Motif Investing sent an email to IPO customers on 01/13 giving us some stats for the year. The text of the email is below. Note: the 25.4% number they reference below is sourced from IPO Boutique and represents all IPOs, not the just ones on Motif. The table on this page tracks the performance of each IPO since it’s opening.
Here’s the text from the email:
When we announced we were bringing you IPOs, we had one goal: to give you more access.
In 2017, Motif gave you access to more than 50 public equity deals, led by 19 different underwriters which raised a total of $4.6 billion for issuing companies. Motif customers can participate in IPOs and other equity public offerings for as little as $250.
Reflecting on the past year, the average gain was 25.4% across all IPO issues on the NYSE and NASDAQ, with two-thirds of IPOs closing the year above their IPO prices. Healthcare was the leading industry sector for IPOs in 2017, followed by technology, consumer and financial.
Heading into 2018, market analysts are forecasting a strong pipeline of deals and expect to see broad participation across industry sectors as companies take advantage of favorable market conditions to launch their offerings.
Update 01/12/2018: ADT IPO now available on Motif Investing. ADT is a leader in home security. Underwriting by Morgan Stanley and Goldman Sachs. $2 billion worth of shares being offered a $17-$19 range. Expected to begin trading 01/19.
ProLung IPO now available on Motif. This company provides “non-invasive lung cancer risk stratification”. Expected to IPO in the range of $7-$8 on 01/25/2018. Underwriting by Maxim Group.
Update 01/09/2018: Nine Energy Service IPO now available on the Motif Investing IPO platform. This is a J.P. Morgan led deal expected to begin trading 01/19/2018. $150 million priced at $20-$23.
Update 12/12/2017: Two new secondary offerings on the Motif platform today. Yield10 Biosciences underwritten by Ladenburg Thalmann and Akers Biosciences underwritten by Joseph Gunnar. Both expected to close on Friday.
Update 12/11/2017: Newmark Group Inc. IPO now available on Motif. This is a Goldman Sachs-led IPO which usually disappear quickly. Act fast!
Expected to begin trading on Friday, December 15th.
Update 12/04/2017: Quanterix IPO led by underwriter J.P. Morgan now available on Motif. Expected to begin trading December 7th.
ClearSign Combustion secondary also available today.
Update 12/01/2017: Adial Pharmaceuticals $14 million IPO now available on Motif. Underwriting by Joseph Gunnar. Expected to price on 12/13 in the range of $9-$11.
Update 11/14/2017: Bluegreen Vacations IPO was briefly available on the Motif platform this afternoon. Underwriting by Stifel, a newcomer to the Motif platform but one of the more reputable firms. Bluegreen is a “vacation ownership” company that runs 43 resort/hotel locations, also known as timeshares.
IPO expected to price 6.5 million shares in the range of $16-$18 for a $110 million valuation.
Update 11/10/2017: Seanergy Maritime secondary available on Motif. Underwriting by Maxim.
Update 11/07/2017: Vical secondary offering available on Motif.
Update 11/02/2017: Funko IPO prices at $12. Opens for trading below $8. Ouch. Lessen #1: IPO investing is risky. Lessen #2: toys for grownups don’t make for good investments.
Update 11/01/2017: Ameri Holdings secondary offering now available on Motif platform. This is an ERP cloud computing company specializing in SAP technology. Secondary expected to close 11/08. Underwriting by Northland Capital Markets.
Update 10/31/2017: ACM Research IPO now available on Motif platform. This company is in the semi-conductor space. It’s expected to be a $17 million IPO underwritten by Roth Capital Partners. Symbol: ACMR.
Update 10/30/2017: Metropolitan Bank Holding Corp. IPO, led by J.P. Morgan is now available on Motif investing for a minimum investment of $250. This a New York-based bank holding company offering a diverse range of customers.
3.1 million shares being offered in the range of $31-$34.
Update 10/24/2017: Two new deals available on Motif this afternoon from a new underwriter on the platform called Leerink Partners. These are both spot secondaries that will close on 10/25/2017.
- Immune Design Secondary
- uniQure Secondary
Update 10/23/2017: Funko IPO now available on Motif.
Update 10/20/2017: Sachem Capital secondary on deck for 10/25. This is the third Sachem offering on the Motif platform (see table below for performance).
Update 10/19/2017: Dolphin Entertainment IPO, symbol DLPN, available on Motif. This is another pink sheet aspiring to list on the Nasdaq.
Update 10/17/2017: LiveXLive Media IPO now available on Motif for $250 minimum. This is a $100 million offering led by BMO Capital Markets. Symbol: LXL.
LiveXLive Media is a digital media platform for live music. Expected to begin trading 10/19.
Update 10/17/2017: RiverNorth Lending Corporation IPO now available on Motif. These are preferred shares due in 2024. Offering 1.2 million shares at $25 for a $30 million valuation. Symbol: RMPL
RiverNorth offers publicly traded equity access to marketplace lending loans available on platforms such as LendingClub, SoFi, and Prosper. These are peer lending platforms where individual investors can invest or borrow. RiverNorth brings this asset to a broader audience.
Update 10/16/2017: CUI Global secondary offering available on Motif. Expected 10/19.
Update 10/12/2017: Allocations are in:
- OrthoPediatrics Corp IPO – 10.1%
- Restoration Robotics IPO – 25.6%
Update 10/11/2017: RumbleOn secondary offering sent out to Motif IPO email list this morning. This secondary is expected to begin trading on 10/18/2017.
Currently trades on the OTCQB and hoping to list on Nasdaq under symbol RMBL. Price estimated around $9.50 according to my calculation. We’re seen a few similar deals include Eastside Distilling.
Update 10/09/2017: Restoration Robotics IPO now available on the Motif Investing platform. 3.125 million shares being offered at $7-$9. Underwriting by new kid on the block, National Securities Corp. Access the latest filing for this and any other recently filed for S-1 or 1-A on the SEC Filings page.
This company specializes hair restoration.
Update 10/06/2017: Annaly Capital (NLY) spot secondary hit the Motif platform yesterday evening. $65 million shares expected to begin trading today around $12.00.
Update 10/03/2017: OrthoPediatrics Corp IPO was briefly available on the Motif Investing platform today. The email from Motif came out at 1:53 pm. Hearing reports the deal was closed within 10 minutes.
This is the first Piper Jaffray led IPO opportunity on Motif indicating that their footprint is growing.
Don’t forget, the ClickIPO platform is ramping up their IPO smartphone app and we expect it to go live this year. Should provide us lots of opportunities if you missed out on this one. Make sure to get on the waiting list.
Update 09/28/2017: Deciphera IPO allocations are delivered. 14.2%. Trading begins today.
Update 09/27/2017: Deciphera IPO prices its up-sized IPO at $17, top of the range. Trading to begin tomorrow.
Update 09/21/2017: Deciphera IPO, another J.P. Morgan-led pharmaceuticals IPO, is now available on Motif for a $250 minimum investment. These have been hot recently.
Pricing expected in the range of $15-$17. Trading estimated to begin 09/28.
Update 09/20/2017: Excellent day! Congratulations to all who participated.
CELC closed up 50%
ZLAB closed up 55%
KRYS closed up 6%.
Investors reported on the Motif share allocations. Celcuity investors received about 50% of requested amount. Zai Labs investors received about 30% of requested. Krystal investors received nearly 100% of requested allocations.
Motif offering a secondary today as well for MTBC. Second appearance on the platform.
Update 09/13/2017: Yesterday, Motif sent out an invitation to invest in a spot secondary offering. We noted this development on 09/07 (below). Spot secondary are quick offerings that open after the market close and take place the next day.
The first of this kind on Motif is AGNC Investment Corp. underwritten by Credit Suisse.
I’ll be tracking these spot offerings on this page. Can’t say enthusiasm is high to invest.
Update 09/12/2017: Zai Lab Limited IPO now available on Motif. J.P. Morgan led, $100 million offering. Estimated to price between $16-$18 on 09/20.
Update 09/08/2017: Krystal IPO now available for participation on Motif Investing IPO platform. Symbol KRYS. $3 million shares to be priced at $9-11 for a $30 million offering. Underwriting led by Ladenburg Thalmann. Estimated to price 09/20.
Krystal is a “gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases”.
Update 09/07/2017: Celcuity IPO now available for participation on Motif Investing. Symbol CELC. Expected to price at $8-$10 for an $18 million offering. Underwriting by newcomer to Motif, Crai-Hallam Capital Group. Estimated to begin trading 09/20.
Received an email last night indication Motif will be participating in “Spot Secondary Offerings”. You need to subscribe separately to receive these deals in your inbox. I only got this email in my active account email address, not the IPO list. Full text of email below:
We are pleased to announce Motif will be offering the opportunity to participate in Spot Secondary Offerings.
What is a Spot Secondary?
A spot secondary is a public offering of already-issued shares, known as a secondary distribution, that does not require a registration statement with the Securities and Exchange Commission (SEC). While a spot secondary is typically offered to institutional investors, Motif is proud to offer the opportunity to individudal investors.
A Short Window
A spot secondary offering can typically be performed more quickly than other types of secondary offerings and, in most cases, a spot secondary offering is announced after market close. The book build (capturing investor demand) for the offering is done very quickly, usually in 2 to 4 hours and will begin trading next day. Shares that are issued through a spot secondary offering are typically priced at a discount to investors.
How Does a Spot Secondary Offering Work on Motif?
Motif Investors who opt into the spot secondary email list will receive email notification on the day of the Spot Secondary, typically 30 minutes after market close. The notification will include the offering details, the time frame in which you can place a funded order, and length of confirmation window upon pricing. The notification will also include a link to the offering prospectus which you can review for further information about the company including historical performance and risks associated with the offer. For more information on public offerings at Motif click here.
Update 08/11/2017: Reports of ~50% allocation for Yogaworks IPO. ~10% for Ranger IPO. Both down in early trading.
Update 08/10/2017: YOGA prices at low end of range: $5.50. RNGR prices below range at $14.50. Both start trading tomorrow.
Yogaworks IPO is back. Expected to price this evening and begin trading Friday. Price range: $5.50-$6.50. Underwriting by Cowen.
Update 08/09/2017: Dynavax secondary offering available on Motif. Expected to close 08/10.
Update 08/03/2017: Ranger Energy Services IPO now available on Motif. Expected to price at $16-$18 for trading to begin on 08/11. Symbol: RNGR
Underwriting by Credit Suisse.
Update 07/31/2017: Redfin IPO traded as high as $24.86 today, from $15 on Friday. This is why we invest in IPOs.
Subscribers we’re alerted 3 days before and got in at the IPO price.
Don’t miss the next opportunity. Subscribe to Access IPOs below:
Update 07/28/2017: Redfin IPO opened trading at $19.56. Traded well into the $20’s. Congrats to everyone involved. Disclosure: Long RDFN.
Redfin IPO allocations are in. 5.742%… BUMMER! Oh well, good luck to everyone participating. This is a cool company with lots of potential.
Lots of disappointment all around. A few positives… Demand was good which bodes well for the opening. Perhaps Goldman Sachs will become a long-term partner with Motif.
Motif is still relatively new at this. So it seems they could have cut off the reservation earlier. Also, the max started at $50,000, which some people probably took advantage of. Later in the day it was lowered to $10,000. No indication if that effected things.
Update 07/27/2016: Received only 16.8% of requested Sienna Pharmaceuticals allocation. Stock begins trading today.
Opening trade $19.05. Now over $19.75 for a 30+% gain.
Update 07/26/2016: Sienna Pharmaceuticals IPO prices mid-range at $15. Trading to begin tomorrow.
Update 07/26/2017: Redfin IPO available on Motif Investing.
Redfin IPO Closed as of 3:00 pm 07/26.
Notable that this Redfin IPO is led by Goldman Sachs. That is big news around here since they are one of the biggest underwriters on the Street. Expected to trade 07/28 in the range of $12-$14.
Latest SEC filings here.
Eastside Distilling secondary offering is also up this morning.
Update 07/24/2017: Frankly IPO now available on Motif. Estimated to price in the range of $4.50-$6.00 on 08/03. Underwritten by Roth Capital Partners, a new underwriter on the Motif platform, along with Joseph Gunnar.
Frankly Inc. helps traditional television broadcasters to utilize new media to distribute content over multiple platforms.
Update 07/20/2017: Update: KALA Closed the day at $18.49, 23.27% one-day gain.
Kala Pharmaceuticals priced midrange at $15. Trading begins today.
Multiple reports of investors receiving ~23% of their reservation amount.
According to IPO Boutique via Twitter, Yogaworks (YOGA) did not price yesterday and has been postponed due to ‘market conditions’.
Update 07/19/2017: Accelerated Pharma IPO is active again. $4-$6 estimated for 07/21. Underwritten by HC Wainwright &Co.
Update 07/18/2017: Sienna Biopharmaceuticals IPO (SNNA) now available on Motif. SNNA is a clinical stage company creating topical medication for skin disorders.
This is a J.P. Morgan led IPO expected to begin trading on 07/27. 4,333,333 shares expected to price in the range of $12-$14 per share for a $65 million offering.
Update 07/17/2017: YogoWorks IPO now available on Motif. This is a $65 million dollar deal underwritten by Cowen.
YogaWorks IPO on Motif estimated for 07/20. Symbol: YOGA
Update 07/12/2017: Kala Pharmaceuticals IPO (KALA) now CLOSED.
Minimum $250 to invest. This IPO is led by J.P. Morgan.
KALA is a biotechnology nanapartical drug company with a proprietary aiming to address eye dryness due to cateract surgery. Phase 3 trials have been promising so far.
This biotechs tends tend to be volatile and are based on potential not earnings. Carefully consider the prospectus and invest at your own risk.
Update 07/12/2017: BBVA Frances secondary now available on Motif Investing platform. Estimates for 07/19. Underwriting by Credit Suisse.
$520 million offering. Symbol: BFR.
Update 06/29/2017: Dova Pharmaceuticals IPO scheduled for today at 10:25 am. Share prices on the high end.
I did not participate due to being on vacation at the release time. How were allocations from Motif?
Reports now coming in from readers: ~27% allocations received.
Update 06/26/2017: Meridian Waste Solution (MRDN) secondary shares offered on Motif Investing. Priced at $2 and anticipated for tomorrow.
Update 06/23/2017: Granite Point Mortgage Trust IPO (GPMT) prices at $19.50. Opens at $18.25.
New secondary offering today on Motif – Reven Housing REIT (RVEN). Anticipated 06/30. Underwritten by a Ladenburg Thalmann.
Update 06/22/2017: SG Blocks IPO (SGBX) opened for trading. Closed the day down 1.6%.
MYnd Analytics (MYND) secondary offering now available on Motif led by Maxim. Expected to price at $6.50 and begin trading 06/29.
This is another stock that previously traded on the OTCQB exchange and has applied to trade on the Nasdaq. No guarantee that will approved.
Update 06/19/2017: Dova Pharmaceuticals IPO now available on Motif. Underwritting by J.P. Morgan. ~4 million shares to price at $15-$17. Estimated for 06/29. Symbol “DOVA”.
Minimum investment: $250. Notable: Max investment amount is currently $50k. Not sure what to make of that.
Update: Dova Pharmaceuticals IPO is CLOSED as of 06/19.
Update 06/16/2017: Granite Point Mortgage Trust IPO now available on Motif Investing. This is the third J.P. Morgan led IPO on Motif. You must be signed in with an account to see this opportunity.
Granite Point (GPMT) is originates and invests in commercial real estate loans. This is a $200 million dollar deal. Shares expected to price at $20-$21 range on Friday 06/23.
Update 06/15/2017: Five Oaks Investment Corp. (OAKS) secondary offering now available on Motif. 4 million shares offered at $5.32, estimated for 06/16. Underwritten by JMP Securities.
Update 06/14/2017: Athenex IPO (ATNX) priced at $11 and began trading this morning. Two readers reporting ~19% allocation of reserved shares. The stocked opened at $12 and ended the day at $12.56.
Update 06/08/2017: Boston Omaha secondary offering now available on Motif Investing for participation. Pricing estimated for 06/15 at $12-$14. Led by Cowan and Company.
Update 06/07/2017: Athenex IPO now available on Motif Investing. That makes SIX IPO and secondary opportunities now available and expected in the next few weeks.
Update 06/05/2017: Medical Transcription Billing Corp. (MTBC) preferred stock offering available on the Motif platform. Estimated for 06/15 at $25 per share. This is the second preferred offering. Also interesting, MTBC had a prior relationship with Loyal3.
Update 06/05/2017: SG Blocks IPO now available for participation on Motif. SG Blocks uses old shipping containers to build new things.
Update 05/17/2017 11am: G1 Therapeutics IPO opened at $15 and fell $14. Now hovering at that level. Lousy market day not helpful.
No exciting pop on this one. Back to the drawing board! Demand was low in this IPO. Shares were available for a while on Motif indicating lack of retail interest. Priced at low end of range.
I received an allocation of about 53% of what I requested.
Two readers reported a similar percentage allocation.
Update 05/10/2017: Mota Group IPO now available on Motif Investing website. The company makes “recreational and commercial drones, smart wearables and innovative mobile accessories for smartphone and camera users.”
This is a small deal of around $6.5 million underwritten by Joseph Gunnar & Co LLC. Expected to begin trading 05/18 under the symbol “MOTA”. Priced at $10.
Update 05/10/2017: G1 Therapeutics IPO available on Motif. This is a legit IPO led by J.P. Morgan. The second of its kind. Act fast, shares will disappear quickly. Do your due diligence after your reservation. You can always back out.
New Info: The IPO is now expected to price on 05/16 for a 05/17 trading debut.